Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4.
D055372:AMP-Activated Protein Kinases; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D018955:CD36 Antigens / Q000378:metabolism*; D004176:Dipyridamole / Q000494:pharmacology*; D004789:Enzyme Activation; D051275:Glucose Transporter Type 4; D006321:Heart / Q000187:drug effects*; D008297:Male; D009004:Monosaccharide Transport Proteins / Q000378:metabolism*; D009097:Multienzyme Complexes / Q000378:metabolism; D009124:Muscle Proteins; D009206:Myocardium / Q000378:metabolism*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D021381:Protein Transport / Q000187:drug effects; D051381:Rats; D011917:Rats, Inbred Lew
D018955:CD36 Antigens; D051275:Glucose Transporter Type 4; D009004:Monosaccharide Transport Proteins; D009097:Multienzyme Complexes; D009124:Muscle Proteins; D010975:Platelet Aggregation Inhibitors; C495694:Slc2a4 protein, rat; D000249:Adenosine Monophosphate; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases